NCT04370639View on ClinicalTrials.gov

A Pilot Study to Assess the Feasibility and Tolerability of the AccuFlow Perfusion Sensor for Intrapartum Hemorrhage

NACompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

May 20, 2020

Primary Completion Date

February 25, 2021

Study Completion Date

February 28, 2021

Conditions
Hemorrhage, PostpartumHemorrhageVasoconstriction
Interventions
DEVICE

AccuFlow sensor

AccuFlow sensor will be worn and survey completed

OTHER

Survey

Patients will be asked to complete a survey regarding device tolerability after completing their cesarean section.

Trial Locations (1)

02905

Women and Infants Hospital of Rhode Island, Providence

All Listed Sponsors
collaborator

ThermaSENSE Corp

UNKNOWN

lead

Megan Lord

OTHER

NCT04370639 - A Pilot Study to Assess the Feasibility and Tolerability of the AccuFlow Perfusion Sensor for Intrapartum Hemorrhage | Biotech Hunter | Biotech Hunter